GLOW: Zolbetuximab plus CAPOX compared with placebo plus CAPOX as first-line treatment for patients with Claudin18. 2+/HER2-Locally advanced unresectable or metastatic gastric …
user-5f8411ab4c775e9685ff56d3（2019）
AI Read Science
Must-Reading Tree
Example
Generate MRT to find the research sequence of this paper
Chat Paper
Summary is being generated by the instructions you defined